What is the difference between semaglutide and tirzepatide?

Semaglutide is a GLP-1 receptor agonist that activates one receptor to reduce appetite and slow digestion. Tirzepatide activates two receptors simultaneously — GLP-1 and GIP — which produces stronger appetite suppression and greater weight loss on average. Semaglutide is the active ingredient in Wegovy and Ozempic. Tirzepatide is the active ingredient in Zepbound and Mounjaro.

Which produces more weight loss, semaglutide or tirzepatide?

Tirzepatide produces greater average weight loss. The SURMOUNT-5 head-to-head trial published in the New England Journal of Medicine shows patients on tirzepatide lost approximately 20.2% of body weight over 72 weeks, compared to 13.7% for semaglutide. 47% more tirzepatide patients achieved 25% or greater body weight loss compared to semaglutide.

Are the side effects different between semaglutide and tirzepatide?

Both medications share a similar gastrointestinal side effect profile. Nausea, vomiting, diarrhea, and constipation are most common during the dose escalation phase. The SURMOUNT-5 trial found no statistically significant difference in GI side effect rates between the two medications. Side effects typically diminish after the first 4 to 8 weeks of treatment.

How much does semaglutide and tirzepatide cost at Elevated Health in Huntington Beach?

At Elevated Health DPC in Huntington Beach, semaglutide is priced at $50 per injection. Tirzepatide ranges from $62.50 to $125 per injection depending on the dose. All physician consultations, dose adjustments, and monitoring visits are included in the monthly Direct Primary Care membership with no copays. Call 714-916-5210 for current membership pricing.

Who should choose tirzepatide over semaglutide?

Tirzepatide is the stronger choice if maximum weight loss is the priority, if you have Type 2 diabetes, or if you have previously tried semaglutide and found results plateaued before reaching your goal. Semaglutide is well-suited for first-time GLP-1 users or patients where cost is the primary constraint.

Semaglutide vs. Tirzepatide: Which GLP-1 Medication Is Right for You?

Q: Can I use my HSA for GLP-1 medications and a DPC membership?

Yes to both. GLP-1 medications are HSA-eligible with a valid prescription. As of January 1, 2026, Direct Primary Care memberships are also federally recognized as HSA-qualified medical expenses under the One Big Beautiful Bill Act, up to $150 per month for individuals and $300 per month for families. At Elevated Health, both your monthly DPC membership and your GLP-1 injections can be paid with pre-tax HSA dollars.

Q: Does Elevated Health accept insurance for GLP-1 treatment?

Elevated Health does not accept health insurance. Patients pay a flat monthly Direct Primary Care membership that covers all office visits with no copays, no referrals, and no prior authorization delays. GLP-1 medication is billed at transparent per-injection pricing. Both the DPC membership and GLP-1 prescriptions are HSA-eligible.

If you’ve looked into GLP-1 therapy for weight loss, you’ve almost certainly run into both semaglutide and tirzepatide. Both are weekly injections. Both produce significant weight loss. Both are available at Elevated Health in Huntington Beach.

But they are not interchangeable. One consistently outperforms the other in head-to-head clinical trials, and the right choice depends on your weight loss goals, your health history, and your budget. This post gives you the full comparison so you can have a more informed conversation at your first visit.

The Short Answer

Tirzepatide produces greater weight loss on average — around 20-22% of body weight at the highest dose versus 15% for semaglutide. It costs slightly more per injection. Both medications are well-tolerated, HSA-eligible with a prescription, and available at Elevated Health with no insurance required. If maximum weight loss is the priority and the cost difference is workable, tirzepatide is the stronger option. If you’re starting GLP-1 therapy for the first time or cost is a tighter constraint, semaglutide is a clinically proven, effective starting point.

How Semaglutide and Tirzepatide Work Differently

Both medications mimic hormones your body naturally produces after eating, which signal your brain to reduce appetite, slow digestion, and regulate blood sugar. The key difference is in how many receptors each one activates.

Semaglutide: Single-Receptor Action

Semaglutide is a GLP-1 receptor agonist. It activates one receptor — the GLP-1 receptor — which reduces appetite and slows gastric emptying. It’s the active ingredient in Wegovy (approved specifically for weight loss) and Ozempic (approved for Type 2 diabetes, widely used off-label for weight management).

Tirzepatide: Dual-Receptor Action

Tirzepatide activates two receptors simultaneously: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). The GIP receptor appears to enhance the appetite-suppressing effects of GLP-1 signaling and may have additional benefits for fat metabolism. This dual mechanism is why tirzepatide consistently produces greater weight loss in clinical trials. It’s the active ingredient in Zepbound (weight loss) and Mounjaro (Type 2 diabetes).

What the Clinical Data Actually Shows

The most definitive comparison comes from the SURMOUNT-5 trial, a direct head-to-head study published in the New England Journal of Medicine comparing tirzepatide 10 mg and 15 mg against semaglutide 2.4 mg in adults with obesity but without diabetes.

Patients on tirzepatide lost an average of 20.2% of their body weight over 72 weeks
Patients on semaglutide lost an average of 13.7% of their body weight over the same period
47% more tirzepatide patients achieved 25% or greater body weight loss compared to semaglutide
Tirzepatide also produced greater reductions in waist circumference across all dose comparisons

A 2024 meta-analysis published in JAMA Internal Medicine analyzing real-world data from over 140,000 patients confirmed the same pattern: tirzepatide produced an average of 4.23 kg more weight loss than semaglutide across all doses and durations studied.

Put in plain terms: if two patients start GLP-1 therapy at the same time and one takes semaglutide while the other takes tirzepatide, the tirzepatide patient is likely to lose roughly 50% more weight over the same treatment period. For someone starting at 200 lbs, that’s the difference between losing around 27 lbs versus losing around 40 lbs.

Side Effects: Is One Harder on Your Stomach?

Both medications share a similar side effect profile because both activate the GLP-1 receptor. The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation, particularly during the dose escalation phase when your body is adjusting to the medication.

The good news is that the SURMOUNT-5 trial found no statistically significant difference in GI side effect rates between the two medications at their respective therapeutic doses. Most patients experience side effects primarily during the first 4 to 8 weeks and find they diminish as the dose stabilizes.

At Elevated Health, your physician monitors you through the titration period and can adjust your escalation schedule if GI symptoms are significant. Slow titration is the most effective way to reduce side effect burden for either medication.

A note on rare but serious risks: Both medications carry a boxed warning regarding a potential risk of thyroid C-cell tumors observed in animal studies. They are not recommended for patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). Your physician will review your health history before prescribing.

Cost at Elevated Health — And How to Pay With Pre-Tax Dollars

Medication Pricing

Semaglutide	$50 per injection
Tirzepatide	$62.50 to $125 per injection (dose-dependent)
Monitoring & visits	Included in DPC monthly membership — no copays
Baseline labs	Included in membership (metabolic panel, A1C, lipid panel)

No Insurance Required — And Both Are HSA-Eligible

Elevated Health does not accept health insurance. You pay a simple monthly membership that covers all your office visits, consultations, and follow-up monitoring with no copays, no referrals, and no prior authorization delays.

As of January 1, 2026, Direct Primary Care memberships are federally recognized as HSA-qualified medical expenses under the One Big Beautiful Bill Act — up to $150/month for individuals and $300/month for families. Your GLP-1 medication is also HSA-eligible with a valid prescription. That means both your membership fee and your injections can be paid with pre-tax dollars from your Health Savings Account.

For patients with an HSA-qualified high-deductible health plan, this combination often makes Elevated Health a more affordable option than going through insurance with copays, deductibles, prior authorization requirements, and specialist referrals.

Which One Is Right for You? A Decision Framework

Choose Semaglutide If:

You are starting GLP-1 therapy for the first time and want to begin with the more established, longer-studied option
Cost is a tighter constraint and the $50 per injection pricing is important
Your weight loss goal is moderate (10-15% of body weight) and semaglutide’s proven efficacy range is sufficient
Your insurance covers Wegovy or Ozempic, making brand-name semaglutide accessible through a separate pharmacy benefit

Choose Tirzepatide If:

Maximum weight loss is the priority and you want the most clinically effective option currently available
You have tried semaglutide and found the results plateaued before reaching your goal
You have Type 2 diabetes, as tirzepatide’s dual mechanism produces stronger glycemic control alongside weight loss
The cost difference between semaglutide and tirzepatide is manageable within your budget
You are comfortable using HSA funds to offset the cost of the higher dose tiers

Not sure which to start with? At Elevated Health, your physician will review your health history, current A1C, lipid panel, and weight loss goals at your initial consultation and make a specific recommendation. There is no single right answer that applies to every patient — the decision is made together based on your full picture.

What About Compounded Semaglutide and Tirzepatide?

You may have seen compounded GLP-1 medications advertised at lower prices from telehealth platforms and compounding pharmacies. A few things worth knowing before making that comparison:

Compounded drugs are not FDA-approved finished products. FDA does not approve compounded formulations — it regulates the facilities that produce them, not the end product.
During the period when semaglutide and tirzepatide were on the FDA shortage list, 503B compounding facilities were permitted to produce these medications legally. The FDA has been tightening enforcement as shortages resolve.
Quality can vary significantly between compounding pharmacies. Reputable 503B facilities operate under stricter oversight than 503A pharmacies.

At Elevated Health, we use pharmaceutical-grade medications with transparent, fixed per-injection pricing. If you have questions about compounded alternatives, your physician can walk through the current regulatory landscape and help you weigh the tradeoffs at your consultation.

Ready to Get Started in Huntington Beach?

Both semaglutide and tirzepatide are available at Elevated Health, prescribed and monitored by your physician, with all follow-up visits included in your DPC membership. Same-week appointments are typically available.

The first step is a consultation where we review your health history, run baseline labs, and determine which medication and starting dose makes the most sense for you.
Book a consultation online or call us at 714-916-5210.